JENNIFER MILLER: Open Payments
NPI 1629323779 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 39 payments from 12 companies in 2025. Trend: 2023 $1,245 · 2024 $546 · 2025 $843
Food & beverage: $753Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $256 |
| Novo Nordisk Inc | 5 | $164 |
| Sage Therapeutics, LLC | 9 | $157 |
| Hologic Sales and Service, LLC | 3 | $71 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Exeltis, USA Inc. | 2 | $35 |
| ABBVIE INC. | 1 | $20 |
| Alkermes, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: Veozah, Wegovy, ZURZUVAE, MYOSURE TISSUE REMOVAL DEVICE, Qelbree, ZEPBOUND, SLYND, NOVASURE.
Industry payments across LA — which companies pay providers there.
